Clinical Trials
As an infrastructure at the German Center for Infection Research (DZIF), the Clinical Trial Unit tracks DZIF's study activities in the “Healex Site Management System (SMS)”. Studies are sorted by indication and are continuously updated.
The study register has recently been expanded to include the category “COVID-19”. For the first time, not only DZIF study activities are presented here: In order to provide a comprehensive overview in the current pandemic situation of planned and already active COVID-19 studies in Germany, the Clinical Trial Unit is cooperating with researchers from various German Centers for Health Research and other networks.
For researchers: If your study is not yet included in our portal, please contact the project management of the Clinical Trial Unit.
ISAC-01
- Overall study
| Acronym | ISRCTN | EudraCT | NCT (clinicaltrials.gov) | DRKS |
|---|---|---|---|---|
A prospective international study of Staph. aureus bacteriamia in adults by the international Staph. aureus Collaboration (ISAC)
Status: Active
Purpose / Objectives
Primary Outcome
The purpose of this evaluation is to record the management and outcome of adults with SAB across multiple European, Asian and North American sites. We aim to establish a broader knowledge base, identify key quality indicators associated with improved outcomes, and to provide comparator data to ensure that patients enrolled in RCTs are representative of bacteraemic S. aureus patients as a whole.
Diagnosis
- pathogenic bacteria
S. aureus cultured from one or more bottles of one or more blood cultures
Target population
Age
18-99
Inclusion criteria
- S. aureus cultured from one or more bottles of one or more blood cultures
- monomicrobial
Study design
- Multicenter
- Prospective
Documents (password protected)
Go to download area (no documents yet)
Responsibilities in overall study
(National) Coordinating Investigator
Dr. med. Achim Kaasch